Kiromic BioPharma Forum: Community User: Summer.76

Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers Alexis ISO-1 is Company’s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers Company Also Provides Guidance on Regulatory Pathway

EU Patent #3220913  for "NANOPARTICLE-BASED VACCINE TARGETING CANCER/TESTIS ANTIGENS AND ITS USE IN SOLID MALIGNANCIES" https://data.epo.org/publication-server/pdf-document?pn=3220913&ki=B1&cc=EP

Diese **** ke hat mein Leben ruiniert ! **** ceo

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights https://www.businesswire.com/news/home/20210813005386/en/Kiromic-BioPharma-Reports-Second-Quarter-2021-Financial-Results-and-Operating-Highlights KIROMIC BIOPHARMA : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) https://www.marketscreener.com/quote/stock/KIROMIC-BIOPHARMA-INC-113902312/news/KIROMIC-BIOPHARMA-Management-s-Discussion-and-Analysis-of-Financial-Condition-and-Results-of-Opera-36161507/

https://register.epo.org/application?number=EP15861304&tab=main

https://last10k.com/sec-filings/krbp/0001558370-21-010146.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=krbp

https://conferencecalltranscripts.com/summary/?id=9698052

Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors https://www.businesswire.com/news/home/20210726005822/en/Kiromic-Announces-the-Acquisition-of-InSilico-Solutions-Leveraging-on-Bioinformatics-and-Artificial-Intelligence-to-Advance-Clinical-Development-on-Its-Outpatient-Allogeneic-CAR-T-for-Solid-Tumors

Ist die ke immer noch net durch oder wie

Warum sinkt es dann mal bei solchen News. Zum kotzen man !!!!

Kiromic BioPharma Provides Update on IND Filings on its Off-the-Shelf, Allogeneic CAR-T for Solid Tumors https://www.businesswire.com/news/home/20210716005444/en/Kiromic-BioPharma-Provides-Update-on-IND-Filings-on-its-Off-the-Shelf-Allogeneic-CAR-T-for-Solid-Tumors

Nie wieder Long bei einer Aktie ich war so schön im plus !!!!! Ich raste noch aus man

Kiromic BioPharma, Inc. Announces Closing of Public Offering https://www.businesswire.com/news/home/20210702005429/en/Kiromic-BioPharma-Inc.-Announces-Closing-of-Public-Offering ...today announced the closing of its previously announced underwritten public offering of 8,000,000 shares of its common stock at a public offering price of $5.00 per share, resulting in gross proceeds to the Company of $40 million. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 1,200,000 shares of common stock, solely to cover over-allotments.  ...

So früh schon eine ke. Man ey